Biotech

Researchers at University of California San Diego School of Medicine and Moores Cancer Center at UC San Diego Health report successfully removing the nucleus out of a type of ubiquitous cell, known as enucleation, then using the genetically engineered cell as a unique cargo-carrier to deliver therapeutics precisely to diseased tissues. The findings published in
0 Comments
Natural selection causes a virus to enhance its evolutionary advantages either by mutations that strengthen its binding with the host cell or by mutations to escape antibody protection. A recent study, published in the Journal of Chemical Information and Modeling, uses an artificial intelligence model to investigate Omicron’s mutations and its infectivity, vaccine escape capability,
0 Comments
The founder of Moderna’s incubator, Flagship Pioneering, penned his first annual letter charting the four driving forces behind the biotech industry’s future with an emphasis on digital biology and platform technologies. Noubar Afeyan, Ph.D., who founded Flagship in 2000 and is its CEO as well as chairman of Moderna, also called on governments and private sector
0 Comments
We’re off for another day of the J.P. Morgan Healthcare Conference. We saw a clamor of research collaboration announcements that defined the first two days of the conference. Now, those announcements have slowed, but there’s plenty of action to come as companies make their pitches to their peers, investors and industry watchers.    And we’re
0 Comments
insights from industryDr. Zhang Lin LinTechnical SpecialistSino Biological Europe In this interview, News-Medical talks to Dr. Zhang Linlin, Technical Specialist at Sino Biological Europe, about their recombinant antibody services and more that they can provide within Europe. Can you explain what services Sino Biological provides? Sino Biological is dedicated to providing the scientific community with
0 Comments
Sana Biotechnology will dish out up to $204 million in biobucks to gain nonexclusive access to a BCMA CAR construct from IASO Biotherapeutics and partner Innovent Biologics.  The construct is part of IASO and Innovent’s autologous BCMA-directed CAR-T cell therapy, CT103A, that is in a phase 1/2 study in patients with relapsed and/or refractory multiple
0 Comments
A team led by University of California, Irvine researchers has developed a new biopsy technology that can profile multiple tumor microenvironment biomarkers simultaneously, revealing cellular spatial organization and interactions that will help advance personalized disease diagnosis and treatment. Current single-biomarker biopsies lack the ability to analyze many different markers and often fail to predict patient
0 Comments
Sarepta Therapeutics could ask the FDA as soon as next year to approve its gene transfer therapy for Duchenne muscular dystrophy, the biotech said Monday at the annual J.P. Morgan Healthcare Conference. The therapy, dubbed SRP-9001, showed “highly” statistically significant improvements at 48 weeks in a functional motor ability test.  Nonetheless, the company’s shares, after
0 Comments
In a recently published article in the journal Nano-Micro Letters, scientists have provided an in-depth review on the application and benefits of nanotechnology in the development of coronavirus disease 2019 (COVID-19) vaccines.   Review: From Bench to the Clinic: The Path to Translation of Nanotechnology-Enabled mRNA SARS-CoV-2 Vaccines Background The recent outbreak of COVID-19 caused by
0 Comments
Atea Pharmaceuticals is still determined to get its COVID-19 antiviral through clinical trials, but without a partner to collaborate with, the biotech is also raiding Merck’s storeroom to make a play in a different indication. The small biotech was previously working with Roche on bemnifosbuvir, but that ended in November when the Swiss pharma cut
0 Comments
Scientists have discovered an antibody that may lead to more effective treatments against a wide range of sarbecoviruses, the family of viruses that includes the coronavirus SARS-CoV-2 and their variants. The antibody neutralizes SARS-CoV-2, SARS-CoV-2 variants and other sarbecoviruses in the lab, protects against infection in animal studies, and appears to be able to thwart
0 Comments